Recently, a growing body of evidence has been presented to show that SDF-1α/CXCR4 stimulation also leads to the secretion of various proteases, such as MMP-2 and MMP-9 by the breast cancer cells, which are then used to degrade the extracellular matrix, thereby facilitating cellular motility. The gene discussed is CXCL12; the disease is breast carcinoma.